Comparison between Speciality Medicines IPO and Wildnet Technologies IPO.
IPO Details
Speciality Medicines IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Wildnet Technologies IPO is a SME Bookbuilding proposed to list at BSE SME.
Issue Size and Price
The total issue size of Speciality Medicines IPO is up to ₹27.28 Cr whereas the issue size of the Wildnet Technologies IPO is up to ₹0.00 Cr. The final issue price of Speciality Medicines IPO is ₹124.00 per share and of Wildnet Technologies IPO is .
| | Speciality Medicines IPO | Wildnet Technologies IPO |
|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹117.00 per share | |
| Issue Price (Upper) | ₹124.00 per share | |
| Issue Price (Final) | ₹124.00 per share | |
| Discount (Retail) | | |
| Discount (Employee) | | |
| Market Lot Size | 1000 shares | |
| Fresh Issue Size | 22,00,000 shares | 3,50,000 shares |
| Fresh Issue Size (Amount) | up to ₹27.28 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 28,00,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 22,00,000 shares | 31,50,000 shares |
| Issue Size Total (Amount) | up to ₹27.28 Cr | up to ₹0.00 Cr |
IPO Timetable
Speciality Medicines IPO opens on Mar 20, 2026, while Wildnet Technologies IPO opens on . The closing date of Speciality Medicines IPO and Wildnet Technologies IPO is Mar 24, 2026, and , respectively.
Financials & KPIs
Speciality Medicines IPO P/E ratio is 9.27, as compared to Wildnet Technologies IPO P/E ratio of .
Shares Offered
In the Speciality Medicines IPO Retail Individual Investors (RII) are offered 10,90,000 shares while in Wildnet Technologies IPO retail investors are offered 10,90,000 shares. Qualified Institutional Buyers (QIB) are offered 21,000 shares in Speciality Medicines IPO and in Wildnet Technologies IPO.
Bids Received (Subscription)
Speciality Medicines IPO subscribed 2.27x in total, whereas Wildnet Technologies IPO subscribed .
